Antipruritic potency of serotonin type 3 (5-HT3) receptor antagonists--a reply

Arch Dermatol. 1999 May;135(5):599-600. doi: 10.1001/archderm.135.5.599.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Foot Dermatoses / drug therapy*
  • Hand Dermatoses / drug therapy*
  • Humans
  • Ondansetron / therapeutic use*
  • Pruritus / drug therapy*
  • Serotonin Antagonists / therapeutic use*

Substances

  • Serotonin Antagonists
  • Ondansetron